CAV1 and neoplasm: Functionally, the augmented expression in tumor cells with low basal levels of CAV-1 reduced COX-2 mRNA and protein levels, beta-catenin-Tcf/Lef and COX-2 gene reporter activity, PGE2 production, and cell proliferation [21].